# CISATRACURIUM BESYLATE
> **ANDA209132** · Abbreviated New Drug Application (Generic) · Sponsor: SOMERSET · Approved 2019-04-24
## Drug
- **FDA Application Number:** ANDA209132
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CISATRACURIUM BESYLATE
- **Generic name:** CISATRACURIUM BESYLATE
- **Active ingredients:** CISATRACURIUM BESYLATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** SOMERSET
- **Manufacturer:** Somerset Therapeutics, LLC
- **First approval:** 2019-04-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209132)
---
*AI Analytics · CC0 1.0*